Literature DB >> 23113525

Parathyroid hormone concentration in geriatric cats with various degrees of renal function.

Natalie C Finch1, Harriet M Syme, Jonathan Elliott.   

Abstract

OBJECTIVE: To determine whether cats in the nonazotemic stages of chronic kidney disease have increased plasma parathyroid hormone (PTH) concentrations as a compensatory physiologic mechanism to maintain plasma phosphate concentration within the reference interval.
DESIGN: Prospective longitudinal study. ANIMALS: 118 client-owned geriatric cats with various degrees of renal function. PROCEDURES: For each cat, a blood sample was obtained for plasma biochemical analysis and determination of plasma PTH concentration, and a urine sample was obtained for determination of urine specific gravity at study entry (baseline) and after 12 months. For a subset of 30 cats, plasma calcitriol concentration was determined at baseline. Cats were categorized into 1 of 3 groups on the basis of kidney function at the end of 12 months. At baseline and after 12 months, plasma concentrations of variables associated with calcium homeostasis were compared between the 3 groups and also within groups over time. Multivariable linear regression was used to identify variables associated with plasma PTH concentration.
RESULTS: Plasma PTH concentration was significantly increased in cats that developed azotemia, compared with PTH concentration in cats that remained nonazotemic, and PTH concentration increased before changes in plasma calcium and phosphate concentrations were detected. A moderate positive association between plasma calcitriol and PTH concentrations was identified. Plasma PTH concentration was associated with age and plasma urea, creatinine, and total calcium concentrations in the final multivariable model. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that renal secondary hyperparathyroidism can develop prior to azotemia in cats, even in the absence of hyperphosphatemia and hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23113525     DOI: 10.2460/javma.241.10.1326

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  10 in total

1.  Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease.

Authors:  Jiabao Lin; Luqi Lin; Siyu Chen; Lifang Yu; Songjie Chen; Zhaofei Xia
Journal:  J Vet Diagn Invest       Date:  2021-02-05       Impact factor: 1.279

2.  Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease.

Authors:  M K Tolbert; S Olin; S MacLane; E Gould; J M Steiner; S Vaden; J Price
Journal:  J Vet Intern Med       Date:  2017-08-20       Impact factor: 3.333

3.  Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.

Authors:  L M Harjes; V J Parker; K Dembek; G S Young; L H Giovaninni; M M Kogika; D J Chew; R E Toribio
Journal:  J Vet Intern Med       Date:  2017-04-17       Impact factor: 3.333

4.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

5.  Relationship between FGF 23, SDMA, Urea, Creatinine and Phosphate in Relation to Feline Chronic Kidney Disease.

Authors:  Simona Grelová; Martina Karasová; Csilla Tóthová; Terézia Kisková; Darina Baranová; Branislav Lukáč; Mária Fialkovičová; Alena Micháľová; Lukáš Kunay; Miroslav Svoboda
Journal:  Animals (Basel)       Date:  2022-08-31       Impact factor: 3.231

6.  The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium-Phosphate Homeostasis in Healthy Older Cats.

Authors:  R F Geddes; V Biourge; Y Chang; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2016-08-16       Impact factor: 3.333

7.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

8.  Evaluation of Electrolyte Concentration and Pro-Inflammatory and Oxidative Status in Dogs with Advanced Chronic Kidney Disease under Dietary Treatment.

Authors:  Doris Pereira Halfen; Douglas Segalla Caragelasco; Juliana Paschoalin de Souza Nogueira; Juliana Toloi Jeremias; Vivian Pedrinelli; Patrícia Massae Oba; Bruna Ruberti; Cristiana Fonseca Ferreira Pontieri; Marcia Mery Kogika; Marcio Antonio Brunetto
Journal:  Toxins (Basel)       Date:  2019-12-19       Impact factor: 4.546

9.  Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats.

Authors:  Hannah J Sargent; Rosanne E Jepson; Yu-Mei Chang; Vincent C Biourge; Esther S Bijsmans; Jonathan Elliott
Journal:  J Vet Intern Med       Date:  2019-09-30       Impact factor: 3.333

Review 10.  A review of phosphorus homeostasis and the impact of different types and amounts of dietary phosphate on metabolism and renal health in cats.

Authors:  Dottie Laflamme; Robert Backus; Scott Brown; Richard Butterwick; Gail Czarnecki-Maulden; Jonathan Elliott; Andrea Fascetti; David Polzin
Journal:  J Vet Intern Med       Date:  2020-11-06       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.